Agreement to focus on research, option, and licensing for discovery of dual tumor-associated antigen-targeting antibodies.
Gilead, Merus Strike Deal to Develop Novel Trispecific T-Cell Antibodies for Cancer Treatment
Agreement to focus on research, option, and licensing for discovery of dual tumor-associated antigen-targeting antibodies.